eMedicine Specialties > Emergency Medicine > Neurology

Bell Palsy

Author: Bruce Lo, MD, Medical Director, Sentara Norfolk General Hospital; Assistant Professor, Assistant Program Director, Core Academic Faculty, Department of Emergency Medicine, Eastern Virginia Medical School
Contributor Information and Disclosures

Updated: Feb 24, 2010

Introduction

Background

Bell's palsy is a unilateral, peripheral facial paresis or paralysis that has an abrupt onset and no detectable cause. Bell palsy is one of the most common neurologic disorders affecting the cranial nerves, and it is certainly the most common cause of facial paralysis worldwide. Although this syndrome was first described in 1821, by the Scottish anatomist and surgeon Sir Charles Bell, much controversy still surrounds its etiology and management.


Left-sided Bell's palsy.

Left-sided Bell's palsy.

Left-sided Bell's palsy.

Left-sided Bell's palsy.


The onset of Bell's palsy can be frightening for patients, who often fear they have had a stroke or have a tumor and that the distortion of their facial appearance will be permanent. Consequently, patients with Bell's palsy frequently present to the ED before seeing any other health care professional.

It is imperative to keep in mind that Bell's palsy is a diagnosis of exclusion. Other disease states or conditions that present as facial palsies are often misdiagnosed as idiopathic. In addition to excluding other causes of facial paralysis, the role of the ED clinician consists of the following:

  • Initiate appropriate treatment.
  • Protect the eye.
  • Arrange appropriate medical follow-up care.

Under Investigation

Variety nonpharmacologic measures have been used to treat Bell's palsy, including physical therapy (eg, facial exercises,1 neuromuscular retraining2 ) and acupuncture.3 No adverse effects of these treatments have been reported. Reviews suggest that physical therapy may result in faster recovery and reduced sequelae, but further randomized controlled trials are needed to confirm any benefit.

Pathophysiology

The precise pathophysiology of Bell's palsy remains an area of continuing debate. A popular theory proposes that inflammation and swelling of the facial nerve results in compression of the nerve within the temporal bone. This has been seen in MRI scans with facial nerve enhancement.4

The facial nerve courses through a portion of the temporal bone commonly referred to as the facial canal. The first portion of the facial canal, the labyrinthine segment, is narrowest; the meatal foramen in this segment has a diameter of only about 0.66 mm. Given the tight confines of the facial canal, it seems logical that inflammatory, demyelinating, ischemic, or compressive processes may impair neural conduction at this site.

Anatomy

The facial nerve (seventh cranial nerve) has 2 components. The larger portion comprises efferent fibers that stimulate the muscles of facial expression. The smaller afferent portion contains taste fibers to the anterior two thirds of the tongue, secretomotor fibers to the lacrimal and salivary glands, and some pain fibers.

The facial nerve.

The facial nerve.

The facial nerve.

The facial nerve.


Pathway

The path of the facial nerve is complex; this may be the reason the nerve is vulnerable to injury. Two portions of the facial nerve leave the brain at the cerebellopontine angle, traverse the posterior cranial fossa, dive into the internal acoustic meatus, pass through the facial canal in the temporal bone, then angle sharply backwards, where they pass behind the middle ear and exit the cranium at the stylomastoid foramen. From here, the facial nerve bisects the parotid gland, and then terminal branches extend from the parotid plexus to innervate the muscles of facial expression.

Frequency

United States

The incidence of Bell's palsy in the United States is approximately 25 cases per 100,000 persons.5 The condition affects approximately 1 person in 65 in a lifetime. However, the incidence is significantly higher in persons with diabetes mellitus than in those without diabetes.6

Bell's palsy can also be recurrent, occurring about 7% of the time.7 Rarely, bilateral simultaneous Bell's palsy can occur at a rate of less than 1% of unilateral facial nerve palsy.8,9

International

The incidence is similar to that in the United States,7,10 with the highest incidence reported in Japan.11

Mortality/Morbidity

Bell's palsy can cause aesthetic, functional, and psychological disturbances in patients who have residual nerve dysfunction during their recovery phase or in patients with incomplete healing.

  • Partial paralysis
  • Motor synkinesis (involuntary movement accompanying a voluntary movement)
  • Autonomic synkinesis (involuntary lacrimation after a voluntary muscle movement)

Race

Incidence of Bell palsy appears to be slightly higher in persons of Japanese descent.

Sex

No difference exists in sex distribution in patients with Bell's palsy.7,10 In women, the overall incidence of Bell's palsy during pregnancy is comparable to that of all women of childbearing age; however, the incidence is high in the third trimester and correspondingly low during early pregnancy.12

Age

The incidence of Bell's palsy increases between the ages of 10 and 30 years. Bell's palsy is least common in persons younger than 10 years and most common in those older than 70 years.10

Clinical

History

Most patients presenting to the ED suspect they have suffered a stroke or have an intracranial tumor. The most common complaint is of weakness on one side of the face.

  • Postauricular pain: Approximately 50% of patients experience pain in the mastoid region.7 The pain frequently occurs simultaneously with the paresis, but precedes the paresis by 2-3 days in about 25% of patients.
  • Tear flow: Two thirds of patients complain about tear flow.7 This is due to the reduced function of the orbicularis oculi in transporting the tears. Fewer tears arrive at the lacrimal sac and overflow occurs. The production of tears is not accelerated.
  • Altered taste: While only one third of patients complain about taste disorders,7 four fifths of patients show a reduced sense of taste. Patients may fail to note reduced taste because of normal sensation in the uninvolved side of the tongue.
  • Dry eyes
  • Hyperacusis: Impaired tolerance to typical levels of noise as a result of paralysis of the stapedius muscle.7

Physical

Findings of facial paralysis are easily recognizable on physical examination. A careful, complete examination excludes other possible causes of facial paralysis. Strongly consider other etiologies if all branches of the facial nerve are not affected.

  • Weakness and/or paralysis from involvement of the facial nerve affects the entire face (upper and lower) on the affected side. Focus attention on the voluntary movement of the upper part of the face on the affected side: in supranuclear lesions such as a cortical stroke (upper motor neuron; above the facial nucleus in the pons), the upper third of the face is spared while the lower two thirds are paralyzed. The orbicularis, frontalis, and corrugator muscles are innervated bilaterally, which explains the pattern of facial paralysis in these cases.10
  • Eye closure on the affected side may be partially or completely impaired. On attempting to close the eye, the patient may demonstrate the Bell phenomenon: the eye on the affected side rolls upward and inward.
  • All the other cranial nerves should be tested; results should be normal.
  • Tympanic membranes should be normal; the presence of inflammation, vesicles, or other signs of infection raises the possibility of complicated otitis media.
  • Concurrent rash or vesicles along the ear canal, pinna, mouth should raise the suspicion for Ramsey-Hunt syndrome (Zoster sine herpete).
  • Bilateral facial palsies should prompt a workup for other causes besides Bell's palsy, although Bell's palsy is the most common etiology.9

Causes

The etiology of Bell's palsy remains unclear, although vascular, infectious, genetic, and immunologic causes have all been proposed. Patients with other diseases or conditions (eg, Lyme disease)13 sometimes develop a peripheral facial nerve palsy, but these are not classified as Bell's palsy (see Differentials).

  • Viral infections: Clinical and epidemiologic data lend credence to an infectious origin, with inflammation and/or a related autoimmune response resulting in local demyelination of the facial nerve. Pathogens leading the list include herpes simplex virus type 1 (HSV-1); herpes simplex virus type 2 (HSV-2); human herpesvirus (HHV); varicella-zoster virus (VZV); influenza B; adenovirus; coxsackievirus; Ebstein-Barr virus; hepatitis A, B, and C viruses; cytomegalovirus (CMV); and rubella virus.14,15,16
  • Mycoplasma infection: Bell's palsy may be a complication of M pneumoniae infection, sometimes in the absence of respiratory symptoms.17
  • Genetics: A family history of Bell's palsy has been reported in approximately 4% of cases. Inheritance in such cases may be autosomal dominant with low penetration. Which predisposing factors are inherited is unclear.18

More on Bell Palsy

Overview: Bell Palsy
Differential Diagnoses & Workup: Bell Palsy
Treatment & Medication: Bell Palsy
Follow-up: Bell Palsy
Multimedia: Bell Palsy
References

References

  1. Teixeira LJ, Soares BG, Vieira VP, Prado GF. Physical therapy for Bell s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. Jul 16 2008;CD006283. [Medline].

  2. Cardoso JR, Teixeira EC, Moreira MD, Fávero FM, Fontes SV, Bulle de Oliveira AS. Effects of exercises on Bell's palsy: systematic review of randomized controlled trials. Otol Neurotol. Jun 2008;29(4):557-60. [Medline].

  3. He L, Zhou MK, Zhou D, Wu B, Li N, Kong SY, et al. Acupuncture for Bell's palsy. Cochrane Database Syst Rev. Oct 17 2007;CD002914. [Medline].

  4. Seok JI, Lee DK, Kim KJ. The usefulness of clinical findings in localising lesions in Bell's palsy: comparison with MRI. J Neurol Neurosurg Psychiatry. Apr 2008;79(4):418-20. [Medline].

  5. Katusic SK, Beard CM, Wiederholt WC, Bergstralh EJ, Kurland LT. Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982. Ann Neurol. Nov 1986;20(5):622-7. [Medline].

  6. Adour K, Wingerd J, Doty HE. Prevalence of concurrent diabetes mellitus and idiopathic facial paralysis (Bell's palsy). Diabetes. May 1975;24(5):449-51. [Medline].

  7. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;4-30. [Medline].

  8. Kim YH, Choi IJ, Kim HM, Ban JH, Cho CH, Ahn JH. Bilateral simultaneous facial nerve palsy: clinical analysis in seven cases. Otol Neurotol. Apr 2008;29(3):397-400. [Medline].

  9. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology. Jul 1994;44(7):1198-202. [Medline].

  10. Gilden DH. Clinical practice. Bell's Palsy. N Engl J Med. Sep 23 2004;351(13):1323-31. [Medline].

  11. Yanagihara N. Incidence of Bell's palsy. Ann Otol Rhinol Laryngol Suppl. Nov-Dec 1988;137:3-4. [Medline].

  12. Vrabec JT, Isaacson B, Van Hook JW. Bell's palsy and pregnancy. Otolaryngol Head Neck Surg. Dec 2007;137(6):858-61. [Medline].

  13. Smouha EE, Coyle PK, Shukri S. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria. Am J Otol. Mar 1997;18(2):257-61. [Medline].

  14. Unlu Z, Aslan A, Ozbakkaloglu B, Tunger O, Surucuoglu S. Serologic examinations of hepatitis, cytomegalovirus, and rubella in patients with Bell's palsy. Am J Phys Med Rehabil. Jan 2003;82(1):28-32. [Medline].

  15. Morgan M, Moffat M, Ritchie L, Collacott I, Brown T. Is Bell's palsy a reactivation of varicella zoster virus?. J Infect. Jan 1995;30(1):29-36. [Medline].

  16. Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope. Jan 2007;117(1):147-56. [Medline].

  17. Völter C, Helms J, Weissbrich B, Rieckmann P, Abele-Horn M. Frequent detection of Mycoplasma pneumoniae in Bell's palsy. Eur Arch Otorhinolaryngol. Aug 2004;261(7):400-4. [Medline].

  18. Yanagihara N, Yumoto E, Shibahara T. Familial Bell's palsy: analysis of 25 families. Ann Otol Rhinol Laryngol Suppl. Nov-Dec 1988;137:8-10. [Medline].

  19. Salinas RA, Alvarez G, Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2004;(4):CD001942. [Medline].

  20. [Best Evidence] Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. Oct 18 2007;357(16):1598-607. [Medline].

  21. Engstrom M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkäranta A, Hultcrantz M, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. Nov 2008;7(11):993-1000. [Medline].

  22. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study. Health Technol Assess. Oct 2009;13(47):iii-iv, ix-xi 1-130. [Medline].

  23. Allen D, Dunn L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2004;CD001869. [Medline].

  24. Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol. Apr 2007;28(3):408-13. [Medline].

  25. Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2009;(4):CD001869. [Medline].

  26. [Best Evidence] Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY. The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ. Sep 7 2009;339:b3354. [Medline].

  27. de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. Sep 2 2009;302(9):985-93. [Medline].

  28. Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Apr 10 2001;56(7):830-6. [Medline].

  29. Kanazawa A, Haginomori S, Takamaki A, Nonaka R, Araki M, Takenaka H. Prognosis for Bell's palsy: a comparison of diabetic and nondiabetic patients. Acta Otolaryngol. Aug 2007;127(8):888-91. [Medline].

  30. Saito O, Aoyagi M, Tojima H, Koike Y. Diagnosis and treatment for Bell's palsy associated with diabetes mellitus. Acta Otolaryngol Suppl. 1994;511:153-5. [Medline].

  31. Sathirapanya P, Sathirapanya C. Clinical prognostic factors for treatment outcome in Bell's palsy: a prospective study. J Med Assoc Thai. Aug 2008;91(8):1182-8. [Medline].

  32. O'Rahilly R, Muller F. Basic Human Anatomy: A Regional Study of Human Structure. Philadelphia, Pa: WB Saunders Co; 1983:391-98.

  33. Olson WH, Brumback RA, Christoferson LA. Practical Neurology for the Primary Care Physician. Springfield, Ill: Thomas Books; 1981:262.

Further Reading

Contributor Information and Disclosures

Author

Bruce Lo, MD, Medical Director, Sentara Norfolk General Hospital; Assistant Professor, Assistant Program Director, Core Academic Faculty, Department of Emergency Medicine, Eastern Virginia Medical School
Bruce Lo, MD is a member of the following medical societies: American College of Emergency Physicians, Emergency Medicine Residents Association, Medical Society of Virginia, Norfolk Academy of Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Edward Bessman, MD, Chairman, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University
Edward Bessman, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

J Stephen Huff, MD, Associate Professor, Emergency Medicine and Neurology, Department of Emergency Medicine, University of Virginia Health Sciences Center
J Stephen Huff, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Neurology, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.